Onconetix Statistics

Total Valuation

Onconetix has a market cap or net worth of $2.77 million. The enterprise value is $8.10 million.

Market Cap	2.77M
Enterprise Value	8.10M

Important Dates

The next estimated earnings date is Friday, May 10, 2024, after market close.

Earnings Date	May 10, 2024
Ex-Dividend Date	n/a

Share Statistics

Onconetix has 22.32 million shares outstanding. The number of shares has increased by 39.44% in one year.

Shares Outstanding	22.32M
Shares Change (YoY)	+39.44%
Shares Change (QoQ)	+8.95%
Owned by Insiders (%)	22.00%
Owned by Institutions (%)	18.63%
Float	21.70M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	47.31
Forward PS	n/a
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	138.50
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.34

Current Ratio	0.34
Quick Ratio	0.27
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-54.72

Financial Efficiency

Return on equity (ROE) is -400.10% and return on invested capital (ROIC) is -841.19%.

Return on Equity (ROE)	-400.10%
Return on Assets (ROA)	-89.30%
Return on Capital (ROIC)	-841.19%
Revenue Per Employee	$4,872
Profits Per Employee	-$3.12M
Employee Count	12
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	-12,593
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -88.53% in the last 52 weeks. The beta is 3.38, so Onconetix's price volatility has been higher than the market average.

Beta (1Y)	3.38
52-Week Price Change	-88.53%
50-Day Moving Average	0.17
200-Day Moving Average	0.45
Relative Strength Index (RSI)	26.45
Average Volume (30 Days)	3,806,262

Short Selling Information

The latest short interest is 527,177, so 2.36% of the outstanding shares have been sold short.

Short Interest	527,177
Short Previous Month	635,626
Short % of Shares Out	2.36%
Short % of Float	2.43%
Short Ratio (days to cover)	1.63

Income Statement

In the last 12 months, Onconetix had revenue of $58,465 and -$37.41 million in losses. Loss per share was -$2.19.

Revenue	58,465
Gross Profit	-1.13M
Operating Income	-36.03M
Pretax Income	-37.42M
Net Income	-37.41M
EBITDA	-36.71M
EBIT	-36.75M
Loss Per Share	-$2.19

Full Income Statement

Balance Sheet

The company has $4.55 million in cash and $9.89 million in debt, giving a net cash position of -$5.33 million or -$0.24 per share.

Cash & Cash Equivalents	4.55M
Total Debt	9.89M
Net Cash	-5.33M
Net Cash Per Share	-$0.24
Equity / Book Value	-5.60M
Book Value Per Share	-0.25
Working Capital	-11.35M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$13.58 million and capital expenditures -$55,044, giving a free cash flow of -$13.64 million.

Operating Cash Flow	-13.58M
Capital Expenditures	-55,044
Free Cash Flow	-13.64M
FCF Per Share	-$0.80

Full Cash Flow Statement

Margins

Gross margin is -1,927.93%, with operating and profit margins of -61,634.47% and -63,986.48%.

Gross Margin	-1,927.93%
Operating Margin	-61,634.47%
Pretax Margin	-64,008.02%
Profit Margin	-63,986.48%
EBITDA Margin	-62,784.10%
EBIT Margin	-62,859.25%
FCF Margin	-23,323.46%

Dividends & Yields

Onconetix does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-39.44%
Shareholder Yield	-39.44%
Earnings Yield	-1,352.48%
FCF Yield	-492.99%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Onconetix has an Altman Z-Score of -2.37 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.37
Piotroski F-Score	1